Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2). J of Skin [Internet]. 2022 Nov. 16 [cited 2026 Apr. 17];6(6):s57. Available from: https://skin.dermsquared.com/skin/article/view/1812